CorSense

EUIPO EUIPO 2024 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark CorSense was filed as Word mark on 09/02/2024 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/09/2025. The current status of the mark is "Trademark registered".

Trademark Details Last update: January 27, 2025

Trademark form Word mark
File reference 019073667
Application date September 2, 2024
Publication date October 2, 2024
Entry date January 9, 2025
Expiration date September 2, 2034

Trademark owner

Waldstraße 14
07639 Bad Klosterlausnitz
DE

Trademark representatives

Hansastr. 32 80686 Munich DE

goods and services

5 Pharmaceuticals and veterinary preparations for the treatment of cardiovascular diseases, heart and circulatory diseases, heart failure, coronary diseases, endovascular diseases, structural heart diseases
10 Surgical, medical, and veterinary apparatus and instruments, namely, surgical or medical devices for treating or diagnose structural heart diseases, surgical or medical devices for treating heart failure, surgical or medical devices for providing endovascular therapy and open heart surgery, heart and lung assist devices, pressure and flow sensors, catheters, stents such as coated stents or self-expanding stents, obliteration devices, occlusion devices, implantable ventricular devices, cannulas; Suture materials; Catheters, in particular balloon catheters; Medical apparatus and instruments for treating structural heart disease; Medical devices to treat heart failure; Medical devices for endovascular therapy; Medical devices for open surgery; Heart and lung support devices, pressure and flow sensors , namely, stents, lung ventilators, implantable ventricular assist devices such as implantable left or right ventricular assist devices, permanent implantable ventricular assist devices; Stents in particular coated stents or self-expanding stents; Obliteration devices, namely, left atrial appendage (LAA) obliteration devices, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Occlusion devices, namely, catheters, stents, patent foramen ovale (PFO) occlusion devices; atrial septal defect (ASD) occlusion devices; ventricular septal defect (VSD) occlusion devices; Implantable ventricular devices, namely intravascular implants comprised of artificial material or implantable ventricular assist devices; Cannulae
44 Medical services

ID: 11019073667